Imagine new medicines that effectively fight cancer, but may result in fewer side effects thanks to more accurate targeting of tumor cells. Today, PhRMA released a new video that highlights these...
Read More

Last week, we looked at what was said about Medicare Part D costs and beneficiary premiums when the program was created – and at what has actually happened in the first 10 years of the program. This...
Read More

When you have a loved one with a rare disease, the importance of persevering to find new, innovative treatments takes on new meaning. This year on Rare Disease Day, I am excited to celebrate the...
Read More

Fighting abuse in Massachusetts: PhRMA was joined by Massachusetts Governor Charlie Baker and President of the Massachusetts Chiefs of Police Association at an event in Boston this week to discuss...
Read More

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More

Every day in Massachusetts, four people die from an opioid overdose. It is one of the most difficult public health challenges facing the Commonwealth, and the country. Prescription drug abuse...
Read More

In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...
Read More

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More

As we reflect on 10 years since the implementation of Medicare Part D, we’re taking a closer look at what was said in the early years after the law was passed and what actually happened. Over the...
Read More

Coverage does not equal access: While the burden of high deductibles has already received significant attention, new data reveals that consumers have no choice but to pay up to thousands of...
Read More

Building on recent stories about the challenges even those with insurance are facing, new data show some consumers have no choice but to pay up to thousands of dollars out of pocket before their...
Read More

Last week, the U.S. Chamber of Commerce’s Global Intellectual Property Center (GIPC) released its fourth annual International IP Index. The Index, which measures the intellectual property (IP)...
Read More

In case you missed it, today’s special edition of #MedicareMonday highlights a new issue brief from the Kaiser Family Foundation on how Medicare negotiation proposals would change the structure of...
Read More

This President’s Day, we wanted to look back at three key moments in the history of Medicare. Creation of Part A and Part B: On July 30, 1965, President Lyndon B. Johnson signed into law the ...
Read More

Today’s “Week in Review” covers the last two weeks of activity here at PhRMA. As you’ll see, we’ve been busy! We’re Fighting Back: Our new From Hope to Cures ad campaign launched on Monday. In it,...
Read More

This weekend on Valentine’s Day, we take time to celebrate our friends, family and significant others with acts of love and attention. But we also have the opportunity during American Heart Month...
Read More

The biopharmaceutical industry is committed to advancing solutions for a competitive, value-based health care system that makes better use of today’s medicines and fosters the development of...
Read More

Once again, new research is pointing to the critical need to reform the 340B program. The latest data, from Berkeley Research Group (BRG), uncovered startling differences in Medicare Part B...
Read More

Last week, we highlighted how changing the structure of the Medicare Part D program would cause more harm than good by restricting beneficiary access to needed medicines. Here’s a look at what is...
Read More

Diagnosed with type 1 diabetes at a young age, five-year-old Rhys has not let his diagnosis be his destiny. He enjoys life to the fullest, from playing sports to having treats at a friend’s...
Read More

More than 1.7 million new cancer cases are expected to be diagnosed in the United States this year. Although that number is daunting, World Cancer Day reminds us that tremendous progress in the...
Read More

We previously noted that it is counterintuitive that more hospitals would become eligible for the 340B discount program as the share of uninsured patients these hospitals serve declines due to the...
Read More

This week on Medicare Monday, we’re looking at how proposals to change the structure of Medicare Part D could actually limit – and hurt – beneficiary access. As we’ve covered before, price...
Read More